Synaptogenix, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US87167T2015
USD
6.67
0.57 (9.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Evoke Pharma, Inc.
Jaguar Health, Inc.
Tempest Therapeutics, Inc.
Synaptogenix, Inc.
Cyclacel Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc.
Artelo Biosciences, Inc.
CNS Pharmaceuticals, Inc.
ZyVersa Therapeutics, Inc.
Petros Pharmaceuticals, Inc.
Universe Pharmaceuticals, Inc.
Why is Synaptogenix, Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Synaptogenix, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Synaptogenix, Inc.
120.86%
0.52
142.23%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
8.39%
EBIT to Interest (avg)
-11.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.87
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.47%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.65
EV to EBIT
1.86
EV to EBITDA
1.86
EV to Capital Employed
1.19
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
64.03%
ROE (Latest)
-113.14%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET SALES(9M)

At USD 0 MM has Grown at inf%

NET PROFIT(HY)

Higher at USD -3.45 MM

-20What is not working for the Company
ROCE(HY)

Lowest at -154.62%

RAW MATERIAL COST(Y)

Grown by 1,758,864% (YoY

CASH AND EQV(HY)

Lowest at USD 33.69 MM

DEBT-EQUITY RATIO (HY)

Highest at -104.98 %

OPERATING PROFIT(Q)

Lowest at USD -2.71 MM

PRE-TAX PROFIT(Q)

Lowest at USD -2.56 MM

NET PROFIT(Q)

Lowest at USD -2.56 MM

EPS(Q)

Lowest at USD -11.26

Here's what is working for Synaptogenix, Inc.
Net Sales
At USD 0 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Here's what is not working for Synaptogenix, Inc.
Pre-Tax Profit
At USD -2.56 MM has Fallen at -103.17%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -2.56 MM has Fallen at -103.17%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit
Lowest at USD -2.71 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -2.56 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -2.56 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -11.26
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv
Lowest at USD 33.69 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -104.98 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 1,758,864% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales